1. Home
  2. ARTL vs NBY Comparison

ARTL vs NBY Comparison

Compare ARTL & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • NBY
  • Stock Information
  • Founded
  • ARTL 2011
  • NBY 2000
  • Country
  • ARTL United States
  • NBY United States
  • Employees
  • ARTL N/A
  • NBY N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • ARTL Health Care
  • NBY
  • Exchange
  • ARTL Nasdaq
  • NBY Nasdaq
  • Market Cap
  • ARTL 3.1M
  • NBY 3.4M
  • IPO Year
  • ARTL N/A
  • NBY 2007
  • Fundamental
  • Price
  • ARTL $1.05
  • NBY $0.55
  • Analyst Decision
  • ARTL Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • ARTL 2
  • NBY 1
  • Target Price
  • ARTL $5.50
  • NBY $0.85
  • AVG Volume (30 Days)
  • ARTL 47.0K
  • NBY 43.9K
  • Earning Date
  • ARTL 05-13-2025
  • NBY 05-15-2025
  • Dividend Yield
  • ARTL N/A
  • NBY N/A
  • EPS Growth
  • ARTL N/A
  • NBY N/A
  • EPS
  • ARTL N/A
  • NBY 0.57
  • Revenue
  • ARTL N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • ARTL N/A
  • NBY $23.91
  • Revenue Next Year
  • ARTL N/A
  • NBY $32.05
  • P/E Ratio
  • ARTL N/A
  • NBY $1.20
  • Revenue Growth
  • ARTL N/A
  • NBY 20.52
  • 52 Week Low
  • ARTL $0.82
  • NBY $0.36
  • 52 Week High
  • ARTL $1.55
  • NBY $4.10
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 58.54
  • NBY 41.00
  • Support Level
  • ARTL $0.90
  • NBY $0.55
  • Resistance Level
  • ARTL $1.02
  • NBY $0.60
  • Average True Range (ATR)
  • ARTL 0.07
  • NBY 0.03
  • MACD
  • ARTL 0.01
  • NBY -0.00
  • Stochastic Oscillator
  • ARTL 62.18
  • NBY 3.45

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: